Minutia CEO Katy Digovich is driving game-changing diabetes research - San Francisco Business Times

  • 📰 SFBusinessTimes
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

Business News News

Business Business Latest News,Business Business Headlines

Katy Digovich's company Minutia is taking on diabetes cell by cell. And for her, the race to build game-changing therapies is personal.

tried to get as far away from Type 1 diabetes as possible — literally and figuratively.

"Ultimately, I got really angry and the switch flipped. If I was born there, I would be dead. That really hit close to home," she said."I took stock of my career and threw myself into the diabetes space." It is an advance, backed recently by a grant from California regenerative medicine funding agency CIRM, that could personalize and simplify care. Now Digovich and her team are trying to bring it home.A lot of the work we've done to date has been with research-grade cell lines, and with CIRM, we are going to be doing this work with a clinically relevant cell line.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 78. in BUSİNESS

Business Business Latest News, Business Business Headlines